Jointly sponsored by the National Lung Cancer Partnership and Research To Practice

Research To Practice
  • Home
  • Patient Interviews
  • Clinician Interviews
  • About Us
  • Contact Us
Understanding Lung Cancer
  • Risks for Developing Lung Cancer
  • Defining Types of Lung Cancer, Stage and When to Use Adjuvant Therapy
Dealing with a Diagnosis of Lung Cancer
  • Coping with Lung Cancer
  • Advice from Health Care Professionals
  • Advice from Survivors and Patients
Exploring Treatment Options
  • Introduction to Adjuvant Therapy
  • Adjuvant Therapy Options After Surgery
  • Deciding on Adjuvant Therapy Options (Including Clinical Trials)
  • Side Effects Associated with Different Chemotherapies
  • Introduction to Targeted Therapies
  • Side Effects Associated with Targeted Therapies
Participating in Clinical Trials
  • Currently Available Clinical Trials for Early Stage Lung Cancer
  • Enrolling in a Clinical Trial
  • Clinical Trials Evaluating Targeted Therapies

Clinical Trials Evaluating Targeted Therapies

Clinical Trials Evaluating Targeted Agents in the Adjuvant Setting
  • Interview with Dr Wakelee
    • Clinical Trials evaluating targeted agents in the adjuvant setting
    • ECOG-E1505: A clinical trial evaluating chemotherapy with or without bevacizumab
  • Interview with Dr Schiller
    • Radiant: A clinical trial evaluating erlotinib with chemotherapy
    • NSABP-C-08: Results of a colorectal cancer trial with bevacizumab in the Adjuvant setting
  • Interview with Ms Eaby
    • EGFR mutations and treatment indications



Copyright © 2009. All Rights Reserved.
If you are a clinician, click here to receive CME credit for reviewing this activity